한글목차

엑소좀 진단 및 치료 시장은 2024-2029년간 10억 1,020만 달러 확대되고, 예측 기간 동안 26.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측됩니다. 엑소좀 진단 및 치료 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 엑소좀 치료에 대한 연구 활성화, 만성 질환에 대한 효과적인 약물에 대한 수요 증가, 암 조기 발견에 대한 관심 증가 등이 시장을 주도하고 있습니다.

이 보고서는 엑소좀 수집의 첨단 기술이 향후 몇 년동안 엑소좀 진단 및 치료 시장의 성장을 가속하는 주요 이유 중 하나로 꼽았습니다. 또한, 개인 맞춤형 의료에서 엑소좀의 잠재력과 재생의료에 대한 관심이 높아지면서 시장 수요가 크게 증가할 것으로 예상됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio 분석

• 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제4장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2024년)
• 시장 전망(2024-2029년)

제5장 시장 규모 실적

• 세계의 엑소좀 진단 및 치료 시장(2019-2023년)
• 용도별 부문 분석(2019-2023년)
• 최종사용자별 부문 분석(2019-2023년)
• 지역별 부문 분석(2019-2023년)
• 국가별 부문 분석(2019-2023년)

제6장 정성 분석

• AI의 영향 : 세계의 엑소좀 진단 및 치료 시장

제7장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제8장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 진단 : 시장 규모와 예측(2024-2029년)
• 치료 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 용도별

제9장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 연구 및 학술기관 : 시장 규모와 예측(2024-2029년)
• 제약 기업 및 바이오테크놀러지 기업 : 시장 규모와 예측(2024-2029년)
• 상업용 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 최종사용자별

제10장 고객 상황

• 고객 상황 개요

제11장 지역별 상황

• 지역별 세분화
• 비교 : 지역별
• 북미 : 시장 규모와 예측(2024-2029년)
• 유럽 : 시장 규모와 예측(2024-2029년)
• 아시아 : 시장 규모와 예측(2024-2029년)
• 기타 : 시장 규모와 예측(2024-2029년)
• 미국 : 시장 규모와 예측(2024-2029년)
• 인도 : 시장 규모와 예측(2024-2029년)
• 독일 : 시장 규모와 예측(2024-2029년)
• 캐나다 : 시장 규모와 예측(2024-2029년)
• 영국 : 시장 규모와 예측(2024-2029년)
• 중국 : 시장 규모와 예측(2024-2029년)
• 일본 : 시장 규모와 예측(2024-2029년)
• 한국 : 시장 규모와 예측(2024-2029년)
• 프랑스 : 시장 규모와 예측(2024-2029년)
• 이탈리아 : 시장 규모와 예측(2024-2029년)
• 지역 상황에 의한 시장 기회

제12장 성장 촉진요인, 과제, 기회 및 성장 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회와 성장 억제요인

제13장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 산업 리스크

제14장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• Aethlon Medical Inc.
• Bio Techne Corp.
• Capricor Therapeutics Inc.
• Evox Therapeutics Ltd.
• HansaBioMed Life Sciences Ltd.
• Hologic Inc.
• JSR Life Sciences LLC
• Merck KGaA
• Miltenyi BIoTec B.V. and Co. KG
• Nanosomix Inc.
• NX PharmaGen Inc.
• QIAGEN N.V.
• Sarepta Therapeutics Inc.
• System Biosciences LLC
• Thermo Fisher Scientific Inc.

제15장 부록

영문목차

The exosome diagnostics and therapeutics market is forecasted to grow by USD 1010.2 mn during 2024-2029, accelerating at a CAGR of 26.5% during the forecast period. The report on the exosome diagnostics and therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by raising research on exosome therapeutics, increasing demand for effective drugs for chronic diseases, and growing focus on early detection of cancer.

Technavio's exosome diagnostics and therapeutics market is segmented as below:

By Application

• Diagnostic
• Therapeutic

By End-user

• Research and academic institutes
• Pharmaceutical and biotechnology companies
• Commercial

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advanced technology in exosome collection as one of the prime reasons driving the exosome diagnostics and therapeutics market growth during the next few years. Also, potential of exosomes in personalized medicine and rising focus on regenerative medicine will lead to sizable demand in the market.

The report on the exosome diagnostics and therapeutics market covers the following areas:

• Exosome Diagnostics And Therapeutics Market sizing
• Exosome Diagnostics And Therapeutics Market forecast
• Exosome Diagnostics And Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading exosome diagnostics and therapeutics market vendors that include Aethlon Medical Inc., Bio Techne Corp., BioCat GmbH, BioVision Inc., Capricor Therapeutics Inc., Cell Guidance Systems Ltd., Clara Biotech Inc., Evox Therapeutics Ltd., HansaBioMed Life Sciences Ltd., Hologic Inc., JSR Life Sciences LLC, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Nanosomix Inc., NX PharmaGen Inc., QIAGEN N.V., ReNeuron Group plc, Sarepta Therapeutics Inc., System Biosciences LLC, and Thermo Fisher Scientific Inc.. Also, the exosome diagnostics and therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Exosome Diagnostics And Therapeutics Market 2019 - 2023
  • Historic Market Size - Data Table on Global Exosome Diagnostics And Therapeutics Market 2019 - 2023 ($ million)
• 5.2 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.3 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.5 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on the Global Exosome Diagnostics and Therapeutics Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

• 8.1 Market segments
  • Chart on Application - Market share 2024-2029 (%)
  • Data Table on Application - Market share 2024-2029 (%)
• 8.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 8.3 Diagnostic - Market size and forecast 2024-2029
  • Chart on Diagnostic - Market size and forecast 2024-2029 ($ million)
  • Data Table on Diagnostic - Market size and forecast 2024-2029 ($ million)
  • Chart on Diagnostic - Year-over-year growth 2024-2029 (%)
  • Data Table on Diagnostic - Year-over-year growth 2024-2029 (%)
• 8.4 Therapeutic - Market size and forecast 2024-2029
  • Chart on Therapeutic - Market size and forecast 2024-2029 ($ million)
  • Data Table on Therapeutic - Market size and forecast 2024-2029 ($ million)
  • Chart on Therapeutic - Year-over-year growth 2024-2029 (%)
  • Data Table on Therapeutic - Year-over-year growth 2024-2029 (%)
• 8.5 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 9.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 9.3 Research and academic institutes - Market size and forecast 2024-2029
  • Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
  • Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
  • Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
  • Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
• 9.4 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
  • Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
  • Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
  • Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
• 9.5 Commercial - Market size and forecast 2024-2029
  • Chart on Commercial - Market size and forecast 2024-2029 ($ million)
  • Data Table on Commercial - Market size and forecast 2024-2029 ($ million)
  • Chart on Commercial - Year-over-year growth 2024-2029 (%)
  • Data Table on Commercial - Year-over-year growth 2024-2029 (%)
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 11.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 11.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 11.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 11.8 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 11.9 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 11.10 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 11.11 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 11.12 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 11.13 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 11.14 South Korea - Market size and forecast 2024-2029
  • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• 11.15 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 11.16 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 Aethlon Medical Inc.
  • Aethlon Medical Inc. - Overview
  • Aethlon Medical Inc. - Product / Service
  • Aethlon Medical Inc. - Key offerings
  • SWOT
• 14.5 Bio Techne Corp.
  • Bio Techne Corp. - Overview
  • Bio Techne Corp. - Business segments
  • Bio Techne Corp. - Key news
  • Bio Techne Corp. - Key offerings
  • Bio Techne Corp. - Segment focus
  • SWOT
• 14.6 Capricor Therapeutics Inc.
  • Capricor Therapeutics Inc. - Overview
  • Capricor Therapeutics Inc. - Product / Service
  • Capricor Therapeutics Inc. - Key offerings
  • SWOT
• 14.7 Evox Therapeutics Ltd.
  • Evox Therapeutics Ltd. - Overview
  • Evox Therapeutics Ltd. - Product / Service
  • Evox Therapeutics Ltd. - Key offerings
  • SWOT
• 14.8 HansaBioMed Life Sciences Ltd.
  • HansaBioMed Life Sciences Ltd. - Overview
  • HansaBioMed Life Sciences Ltd. - Product / Service
  • HansaBioMed Life Sciences Ltd. - Key offerings
  • SWOT
• 14.9 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Business segments
  • Hologic Inc. - Key news
  • Hologic Inc. - Key offerings
  • Hologic Inc. - Segment focus
  • SWOT
• 14.10 JSR Life Sciences LLC
  • JSR Life Sciences LLC - Overview
  • JSR Life Sciences LLC - Product / Service
  • JSR Life Sciences LLC - Key offerings
  • SWOT
• 14.11 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 14.12 Miltenyi Biotec B.V. and Co. KG
  • Miltenyi Biotec B.V. and Co. KG - Overview
  • Miltenyi Biotec B.V. and Co. KG - Product / Service
  • Miltenyi Biotec B.V. and Co. KG - Key news
  • Miltenyi Biotec B.V. and Co. KG - Key offerings
  • SWOT
• 14.13 Nanosomix Inc.
  • Nanosomix Inc. - Overview
  • Nanosomix Inc. - Product / Service
  • Nanosomix Inc. - Key offerings
  • SWOT
• 14.14 NX PharmaGen Inc.
  • NX PharmaGen Inc. - Overview
  • NX PharmaGen Inc. - Product / Service
  • NX PharmaGen Inc. - Key offerings
  • SWOT
• 14.15 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key news
  • QIAGEN N.V. - Key offerings
  • SWOT
• 14.16 Sarepta Therapeutics Inc.
  • Sarepta Therapeutics Inc. - Overview
  • Sarepta Therapeutics Inc. - Product / Service
  • Sarepta Therapeutics Inc. - Key offerings
  • SWOT
• 14.17 System Biosciences LLC
  • System Biosciences LLC - Overview
  • System Biosciences LLC - Product / Service
  • System Biosciences LLC - Key offerings
  • SWOT
• 14.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations